Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.00 | N/A |
| PEG Ratio (TTM) | -1.72 | N/A |
| P/S Ratio (TTM) | 0.73 | N/A |
| P/B Ratio (TTM) | 1.32 | N/A |
| P/FCF Ratio (TTM) | 12.04 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.50 | N/A |
| Price to 5YR AVG FCF Ratio | 13.55 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.08% | N/A |
| ROE (TTM) | 9.53% | N/A |
| Net Profit Margin (TTM) | 5.11% | N/A |
| ROIC 5YR AVG | 7.55% | N/A |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.32% | 138.10% | 83.25% |
| Revenue | 0.11% | 1.49% | 1.52% |
| Net Income | -1.71% | 131.38% | 77.68% |
| Cash Flow | 10.39% | 6.74% | -0.05% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.31 | N/A |
| Quick Ratio (TTM) | 0.29 | N/A |
| D/E Ratio (TTM) | 0.38 | N/A |
| Interest Coverage (TTM) | 6.78 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.61 | N/A |
| LTL to 5YR AVG FCF | 9.94 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.29% | N/A |